주식/증권 📈 긍정적 Verrica targets COVE-3 initiation by mid-2026 as Q1 dispensed YCANTH units rise 12.1% sequentially Seeking Alpha - Market News 2026/05/13 01:42:09 21회 원문 기사 보기